Brief: PLx Pharma Says On April 4, Received Notice From Nasdaq That Co Had Not Regained Compliance With Listing Rule, Not Eligible For Second 180 Day Period

PLx Pharma Winddown

10/04/2023 21:41

April 10 (Reuters) - PLx Pharma Inc  PLXP.O :
    * PLX PHARMA - ON APRIL 4, RECEIVED NOTICE FROM NASDAQ THAT
CO HAD
NOT REGAINED COMPLIANCE WITH LISTING RULE, NOT ELIGIBLE FOR
SECOND 180 DAY PERIOD
    * PLX PHARMA - UNLESS CO REQUESTS APPEAL OF NASDAQ'S
DETERMINATION
TRADING OF CO'S COMMON STOCK WILL BE SUSPENDED AT OPENING OF
BUSINESS ON APRIL 13

Source text for Eikon:  ID: 
Further company coverage:  PLXP.O 

 ((Reuters.Brief@thomsonreuters.com;))